Back
HuagongsheHuagongshe Chemistry Print Report · For research reference only
HRID 2097581Generated: October 27, 2026

2-[3-(2-Methoxyethoxy)phenyl]-4,4,5,5-tetramethyl-1,3,2-dioxaborolane → 3-{5-[3-(2-Methoxy-ethoxy)-phenyl]-pyridin-2-oxy}-azetidine-1-carboxylic acid pyridazin-3-ylamide

https://huagongshe.com/reaction/2097581

Reaction equation

Participants

RoleNameHCIDCharge
Reactant2-[3-(2-Methoxyethoxy)phenyl]-4,4,5,5-tetramethyl-1,3,2-dioxaborolaneHCID 59558740—
ReactantUS10918640, Example 14HCID 66710496—
Product3-{5-[3-(2-Methoxy-ethoxy)-phenyl]-pyridin-2-oxy}-azetidine-1-carboxylic acid pyridazin-3-ylamideHCID 4421889725%

Reaction Steps

This compound was prepared in similar fashion to the method outlined for Example 5 step 6. Thus 3-(5-iodo-pyridin-2-yloxy)-azetidine-1-carboxylic acid pyridazin-3-ylamide (456 mg, 1.15 mmol) was reacted with 2-[3-(2-Methoxy-ethoxy)-phenyl]-4,4,5,5-tetramethyl-[1,3,2]dioxaborolane (example 5 step 5, 392 mg, 1.50 mmol) to afford title compound (120 mg, 25%) as a colourless powder.

Provenance & Evidence

DOI10.6084/m9.figshare.5104873.v1
Patent numberUS08450346B2
Source datasetuspto-grants-2013_05
ORD IDord-cf0f1290b8144ddc981081997d41bdef
Source noteuspto-grants-2013_05